FGF2 and bipolar disorder: We identified preliminary evidence that peripheral growth factor proteins – the BDNF, the bFGF and VEGF – may moderate the effect of cognitive remediation in those with bipolar disorders, and potentially represent a mechanism for the effect of treatment on functioning.